West Family Investments, Inc. Genmab A/S Transaction History

West Family Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$26.83 - $38.57 $170,370 - $244,919	-6,350 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$30.95 - $39.68 $9,285 - $11,904	300 Added 4.96%	6,350 $229,000
Q4 2021 Feb 07, 2022	SELL	$35.87 - $47.12 $73,892 - $97,067	-2,060 Reduced 25.4%	6,050 $239,000
Q3 2021 Oct 25, 2021	BUY	$41.55 - $48.72 $66,480 - $77,952	1,600 Added 24.58%	8,110 $354,000
Q2 2021 Aug 12, 2021	BUY	$32.88 - $44.57 $214,048 - $290,150	6,510 New	6,510 $266,000

233

52.3M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $12.7B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on West Family Investments, Inc. with notifications on news.